Mizuho Securities USA LLC increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 46.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 14,559 shares of the semiconductor company’s stock after purchasing an additional 4,624 shares during the quarter. Mizuho Securities USA LLC’s holdings in Synopsys were worth $7,066,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SNPS. PNC Financial Services Group Inc. increased its stake in shares of Synopsys by 6.4% in the third quarter. PNC Financial Services Group Inc. now owns 24,715 shares of the semiconductor company’s stock worth $12,515,000 after acquiring an additional 1,494 shares during the last quarter. Jennison Associates LLC increased its position in Synopsys by 41.1% in the 3rd quarter. Jennison Associates LLC now owns 13,802 shares of the semiconductor company’s stock worth $6,989,000 after purchasing an additional 4,017 shares during the last quarter. Citizens Financial Group Inc. RI purchased a new stake in shares of Synopsys during the 3rd quarter worth about $229,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in shares of Synopsys by 12.5% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 40,252 shares of the semiconductor company’s stock valued at $20,383,000 after buying an additional 4,463 shares during the last quarter. Finally, Banco Santander S.A. grew its stake in shares of Synopsys by 283.9% in the 3rd quarter. Banco Santander S.A. now owns 1,363 shares of the semiconductor company’s stock valued at $690,000 after buying an additional 1,008 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Synopsys
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the sale, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Geus Aart De sold 15,705 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the sale, the insider now owns 116,671 shares in the company, valued at approximately $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 47,909 shares of company stock valued at $22,794,835 in the last ninety days. Company insiders own 0.62% of the company’s stock.
Synopsys Trading Down 0.3 %
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on SNPS shares. Needham & Company LLC reaffirmed a “buy” rating and set a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. Piper Sandler reduced their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Robert W. Baird lowered their target price on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $660.00 price target on shares of Synopsys in a research report on Tuesday, February 25th. Finally, Wells Fargo & Company decreased their price target on Synopsys from $540.00 to $520.00 and set an “equal weight” rating for the company in a research note on Thursday, February 27th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $638.58.
View Our Latest Research Report on SNPS
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Start Investing in Real Estate
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.